Hedge Funds Are Selling Codexis, Inc. (CDXS)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows...
Posts Tagged ‘NASDAQ:CDXS’
Hedge Funds Are Dumping Codexis, Inc. (CDXS)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first...
Is Codexis, Inc. (CDXS) A Good Stock To Buy ?
How do we determine whether Codexis, Inc. (NASDAQ:CDXS) makes for a good investment at the moment? We analyze the sentiment of a select group of the very...
Hedge Funds Have Never Been This Bullish On Codexis, Inc. (CDXS)
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value...
Hedge Fund and Insider Trading News: Tom Steyer, Odey Asset Management, Netflix, Inc. (NFLX), Codexis, Inc. (CDXS), Appian Corp (APPN), and More
Trump Nemesis Steyer Locked in Messy Fight Over Clean Power (Bloomberg) Hedge fund billionaire Tom Steyer is spending millions of dollars to turn politically...
Hedge Fund and Insider Trading News: Carl Icahn, Barings BDC Inc (BBDC), Pure Storage Inc (PSTG), Herman Miller, Inc. (MLHR), and More
Carl Icahn Wants to Fight Dell Again (Bloomberg) In 2013, Michael Dell and his private-equity backers at Silver Lake took Dell Inc. private for about $...
Here’s What Is Going On In The Financial Markets Today?
1. US Stock Market: “Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria...
BP plc (ADR) (BP) & More: Gevo, Inc. (GEVO) Begins Countdown to Ethanol’s End
There have been two pops of at least 20% for industrial biotech in the last week — both on the heels of expected news, nonetheless. Last week Codexis...
BASF Se-spon Adr (BASFY), Codexis, Inc. (CDXS): World’s Largest Chemical Company Makes a Splash in Enzymes
It was only a matter of time. Last month BASF Se-spon Adr (OTCBB:BASFY), the world’s largest chemical company, announced three separate developments...
Codexis, Inc. (CDXS): This Biotech Stock Keeps Investors Patiently Waiting
Synthetic biology company and industrial bio-enzyme manufacturer Codexis, Inc. (NASDAQ:CDXS) announced its first-quarter earnings after the market closed...
Valero Energy Corporation (VLO), BP plc (ADR) (BP), Codexis, Inc. (CDXS): Why Big Oil Is Ditching Biotechnology
Landing partners with deep pockets will be critical for many developmental stage biotechnology companies looking to take their disruptive platforms to...
Microsoft Corporation (MSFT), Intel Corporation (INTC), GlaxoSmithKline plc (ADR) (GSK): 8 Projects Bringing Synthetic Biology to Your Doorstep
Bacteria have been Public Enemy No. 1 for most of our species’ time on Earth. Although Sir Alexander Fleming discovered penicillin in 1928, it wasn...
Codexis, Inc. (CDXS) Eyes Raizen With Latest Enzymes: Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Aside from a former partnership with Royal Dutch Shell plc (ADR) (NYSE:RDS-A), industrial biotechnology company Codexis, Inc. (NASDAQ:CDXS) has had...
A Tough Road Ahead for This Big Pharma Partner: Codexis, Inc. (CDXS), Royal Dutch Shell plc (ADR) (RDS.A)
Bio-based enzyme producer Codexis, Inc. (NASDAQ:CDXS) reported financial results for the fourth quarter and full-year 2012 last week. How did things go...
What Does Solazyme Inc (SZYM)’s 500,000-Liter Fermenter Really Mean?
At the end of 2012, renewable-oils manufacturer Solazyme Inc (NASDAQ:SZYM) announced that it had performed two upstream process runs in 500,000-liter...
3 Reasons to Buy Solazyme Inc (SZYM)
When you go out to a restaurant, would you rather read through a menu with limited options or one with exponential potential to send you into a food coma...
